HANOPIRIDE Injection contains Levosulpiride (12.5 mg/ml), a selective dopamine D2-receptor antagonist. It is commonly prescribed for the management of gastrointestinal and psychiatric disorders.
This injection is available in 5 x 2 ml ampoules and is intended for intramuscular (I.M.) or intravenous (I.V.) use only, under medical supervision.
Reviews
There are no reviews yet.